JP Stock MarketDetailed Quotes
4884 Kringle Pharma
- 1217
- +22+1.84%
20min DelayTrading Jan 20 14:17 JST
8.32BMarket Cap-10.30P/E (Static)
1265High1181Low147.30KVolume1249Open1195Pre Close179.99MTurnover132852wk High3.01%Turnover Ratio6.84MShares39452wk Low-118.21EPS TTM5.96BFloat Cap1780Historical HighLossP/E (Static)4.90MShs Float394Historical Low-118.21EPS LYR7.03%Amplitude--Dividend TTM3.93P/B100Lot Size--Div YieldTTM
About Kringle Pharma Company
Kringle Pharma Inc is engaged in the research and development of HGF (hepatocyte growth factor) protein as a therapeutic agent for intractable diseases.
Company Profile
Symbol4884
Company NameKringle Pharma
Founded2001-12-21
MarketTSE Growth
Fiscal Year Ends09-30
Address7-7-15 Saitoasagi 207 Saito Bio-Incubator
Zip Code567-0085
Phone072-641-8739
Websitewww.kringle-pharma.com
Company Executives
- Name
- Position
- Salary
- Yoshikazu Adachi
- President and Chief Executive Officer
- --
- Yoshiyuki Kayano
- Director, General Manager of Reliability Assurance Department
- --
- Koichi Murakami
- Director and General Manager of Corporate Administration
- --
- Daima Hayata
- Director, General Manager of Pharmaceutical Development Department and General Manager of Pharmaceutical Affairs Department
- --
- Tomoho Masataku
- Director
- --
- Masato Fukui
- Independent Director
- --
- Koichiro Yoshino
- Independent Director
- --
Heat List
JP
Overall
Symbol
Price
% Chg
No Data